Clinical Trial for People with Rheumatoid Disease
February 2, 2017 in Events
Join us in the search for new treatment options for RA
For some people with moderate or severe Rheumatoid Arthritis (RA) symptoms, medications that have traditionally been used for the treatment of RA may not work well enough or may cause unwanted side effects. This study is for people whose RA has not responded well enough to previous treatment with methotrexate, and will be comparing the investigational medication with adalimumab (an approved treatment for RA) and placebo (which looks the same as the investigational medication, but contains no actual medication). The investigational medication blocks a certain protein involved in the function of immune cells, and may help to reduce inflammation and damage to the joints caused by RA.